Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio

Cyprinid herpesvirus 2 (CyHV-2) causes herpesviral hematopoietic necrosis (HVHN) disease outbreaks in farmed Cyprinid fish, which leads to serious economic losses worldwide. Although oral vaccination is considered the most suitable strategy for preventing infectious diseases in farmed fish, so far t...

Full description

Bibliographic Details
Main Authors: Zhao-Ran Dong, Qing-Jiang Mu, Wei-Guang Kong, Da-Cheng Qin, Yong Zhou, Xin-You Wang, Gao-Feng Cheng, Yang-Zhi Luo, Tao-Shan Ai, Zhen Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.932722/full
_version_ 1818161981474996224
author Zhao-Ran Dong
Qing-Jiang Mu
Wei-Guang Kong
Da-Cheng Qin
Yong Zhou
Xin-You Wang
Gao-Feng Cheng
Yang-Zhi Luo
Tao-Shan Ai
Zhen Xu
Zhen Xu
author_facet Zhao-Ran Dong
Qing-Jiang Mu
Wei-Guang Kong
Da-Cheng Qin
Yong Zhou
Xin-You Wang
Gao-Feng Cheng
Yang-Zhi Luo
Tao-Shan Ai
Zhen Xu
Zhen Xu
author_sort Zhao-Ran Dong
collection DOAJ
description Cyprinid herpesvirus 2 (CyHV-2) causes herpesviral hematopoietic necrosis (HVHN) disease outbreaks in farmed Cyprinid fish, which leads to serious economic losses worldwide. Although oral vaccination is considered the most suitable strategy for preventing infectious diseases in farmed fish, so far there is no commercial oral vaccine available for controlling HVNN in gibel carp (C. auratus gibelio). In the present study, we developed for the first time an oral vaccine against CyHV-2 by using yeast cell surface display technology and then investigated the effect of this vaccine in gibel carp. Furthermore, the protective efficacy was evaluated by comparing the immune response of a single vaccination with that of a booster vaccination (booster-vaccinated once 2 weeks after the initial vaccination). Critically, the activities of immune-related enzymes and genes expression in vaccine group, especially in the booster vaccine group, were higher than those in the control group. Moreover, strong innate and adaptive immune responses could be elicited in both mucosal and systemic tissues after receipt of the oral yeast vaccine. To further understand the protective efficacy of this vaccine in gibel carp, we successfully developed the challenge model with CyHV-2. Our results showed the relative percent survival was 66.7% in the booster vaccine group, indicating this oral yeast vaccine is a promising vaccine for controlling CyHV-2 disease in gibel carp aquaculture.
first_indexed 2024-12-11T16:26:24Z
format Article
id doaj.art-29c2511522d04e7f8de3c272b5a8a09e
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T16:26:24Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-29c2511522d04e7f8de3c272b5a8a09e2022-12-22T00:58:43ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.932722932722Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelioZhao-Ran Dong0Qing-Jiang Mu1Wei-Guang Kong2Da-Cheng Qin3Yong Zhou4Xin-You Wang5Gao-Feng Cheng6Yang-Zhi Luo7Tao-Shan Ai8Zhen Xu9Zhen Xu10Department of Aquatic Animal Medicine, College of Fisheries, Huazhong Agricultural University, Wuhan, ChinaDepartment of Aquatic Animal Medicine, College of Fisheries, Huazhong Agricultural University, Wuhan, ChinaState Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, ChinaDepartment of Aquatic Animal Medicine, College of Fisheries, Huazhong Agricultural University, Wuhan, ChinaYangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, ChinaDepartment of Aquatic Animal Medicine, College of Fisheries, Huazhong Agricultural University, Wuhan, ChinaDepartment of Aquatic Animal Medicine, College of Fisheries, Huazhong Agricultural University, Wuhan, ChinaWuhan Chopper Fishery Bio-Tech Co., Ltd, Wuhan Academy of Agricultural Science, Wuhan, ChinaWuhan Chopper Fishery Bio-Tech Co., Ltd, Wuhan Academy of Agricultural Science, Wuhan, ChinaState Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, ChinaLaboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, ChinaCyprinid herpesvirus 2 (CyHV-2) causes herpesviral hematopoietic necrosis (HVHN) disease outbreaks in farmed Cyprinid fish, which leads to serious economic losses worldwide. Although oral vaccination is considered the most suitable strategy for preventing infectious diseases in farmed fish, so far there is no commercial oral vaccine available for controlling HVNN in gibel carp (C. auratus gibelio). In the present study, we developed for the first time an oral vaccine against CyHV-2 by using yeast cell surface display technology and then investigated the effect of this vaccine in gibel carp. Furthermore, the protective efficacy was evaluated by comparing the immune response of a single vaccination with that of a booster vaccination (booster-vaccinated once 2 weeks after the initial vaccination). Critically, the activities of immune-related enzymes and genes expression in vaccine group, especially in the booster vaccine group, were higher than those in the control group. Moreover, strong innate and adaptive immune responses could be elicited in both mucosal and systemic tissues after receipt of the oral yeast vaccine. To further understand the protective efficacy of this vaccine in gibel carp, we successfully developed the challenge model with CyHV-2. Our results showed the relative percent survival was 66.7% in the booster vaccine group, indicating this oral yeast vaccine is a promising vaccine for controlling CyHV-2 disease in gibel carp aquaculture.https://www.frontiersin.org/articles/10.3389/fimmu.2022.932722/fullCyHV-2gibel carpyeast surface displayoral vaccinationprotective efficacymucosal immune response
spellingShingle Zhao-Ran Dong
Qing-Jiang Mu
Wei-Guang Kong
Da-Cheng Qin
Yong Zhou
Xin-You Wang
Gao-Feng Cheng
Yang-Zhi Luo
Tao-Shan Ai
Zhen Xu
Zhen Xu
Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio
Frontiers in Immunology
CyHV-2
gibel carp
yeast surface display
oral vaccination
protective efficacy
mucosal immune response
title Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio
title_full Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio
title_fullStr Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio
title_full_unstemmed Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio
title_short Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio
title_sort gut mucosal immune responses and protective efficacy of oral yeast cyprinid herpesvirus 2 cyhv 2 vaccine in carassius auratus gibelio
topic CyHV-2
gibel carp
yeast surface display
oral vaccination
protective efficacy
mucosal immune response
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.932722/full
work_keys_str_mv AT zhaorandong gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT qingjiangmu gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT weiguangkong gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT dachengqin gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT yongzhou gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT xinyouwang gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT gaofengcheng gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT yangzhiluo gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT taoshanai gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT zhenxu gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio
AT zhenxu gutmucosalimmuneresponsesandprotectiveefficacyoforalyeastcyprinidherpesvirus2cyhv2vaccineincarassiusauratusgibelio